Hisakazu Yamagishi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Efficacy of Adjuvant Chemotherapy for T1-2 Stage III Colorectal Cancer.

Efficacy of Adjuvant Chemotherapy for T1-2 Stage III Colorectal Cancer.

Journal: Cancers

Published: November 03, 2025

Neoantigen dendritic cell vaccination combined with conventional chemotherapy for a patient with advanced transverse colon cancer.

Neoantigen dendritic cell vaccination combined with conventional chemotherapy for a patient with advanced transverse colon cancer.

Journal: Journal of surgical case reports

Published: October 20, 2025

Efficacy and safety of oral 5-FU-based adjuvant chemotherapy for geriatric patients with colorectal cancer: Integrated analysis of seven clinical trials conducted at the Japanese Foundation for Multidisciplinary Treatment of Cancer.

Efficacy and safety of oral 5-FU-based adjuvant chemotherapy for geriatric patients with colorectal cancer: Integrated analysis of seven clinical trials conducted at the Japanese Foundation for Multidisciplinary Treatment of Cancer.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: September 05, 2025

Benefit-risk balance of S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).

Benefit-risk balance of S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).

Journal: The oncologist

Published: May 16, 2025

Adverse events of postoperative adjuvant chemotherapy predict survival outcomes in locally advanced colorectal cancer: a pooled analysis of Japanese clinical trials.

Adverse events of postoperative adjuvant chemotherapy predict survival outcomes in locally advanced colorectal cancer: a pooled analysis of Japanese clinical trials.

Journal: British journal of cancer

Published: April 07, 2025

"Evaluation of neprilysin activity in Adipose-Derived stem cells from Alzheimer's disease patients".

"Evaluation of neprilysin activity in Adipose-Derived stem cells from Alzheimer's disease patients".

Journal: Neuroscience letters

Published: November 30, 2023

Feasibility and Safety of Adjuvant Chemotherapy for Resected Colorectal Cancer in Patients With Renal Insufficiency: A Pooled Analysis of Individual Patient Data from Five Japanese Large-scale Clinical Trials.

Feasibility and Safety of Adjuvant Chemotherapy for Resected Colorectal Cancer in Patients With Renal Insufficiency: A Pooled Analysis of Individual Patient Data from Five Japanese Large-scale Clinical Trials.

Journal: Anticancer research

Published: April 13, 2023

Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial.

Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 05, 2022

Repeated infusion of autologous adipose tissue-derived stem cells for Parkinson's disease.

Repeated infusion of autologous adipose tissue-derived stem cells for Parkinson's disease.

Journal: Acta neurologica Scandinavica

Published: June 28, 2021

Perspectives on Stem Cell-Based Regenerative Medicine with a Particular Emphasis on Mesenchymal Stem Cell Therapy.

Perspectives on Stem Cell-Based Regenerative Medicine with a Particular Emphasis on Mesenchymal Stem Cell Therapy.

Journal: JMA journal

Published: April 27, 2021

The mesenchymal stem cells will break down and remove the abnormal proteins that have become insoluble and deposited.

The mesenchymal stem cells will break down and remove the abnormal proteins that have become insoluble and deposited.

Journal: Medical hypotheses

Published: March 26, 2021

Re: Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series.

Re: Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series.

Journal: Clinical neurology and neurosurgery

Published: March 15, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026